Lisa Flavin
Insider
First SEC filing: March 12, 2021 · Latest: June 10, 2026
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 8, 2026 | CAL | A | 12,196 | $13.12 | $160,012 | 12,196 Direct | · | Acquired | -6.9% (price as of 2026-10-02) |
| Nov. 6, 2025 | EMR | F | 1,002 | $132.71 | $132,975 | 96,548 Direct | -1.03% | Disposed | 21.8% (price as of 2026-10-02) |
| Nov. 4, 2025 | EMR | F | 842 | $138.32 | $116,465 | 97,550 Direct | -0.86% | Disposed | 16.8% (price as of 2026-10-02) |
| Nov. 3, 2025 | EMR | A | 19,773 | · | · | 101,997 Direct | +24.05% | Acquired | (price as of 2026-10-02) |
| Nov. 3, 2025 | EMR | F | 8,712 | $139.46 | $1,214,976 | 93,285 Direct | -8.54% | Disposed | 15.9% (price as of 2026-10-02) |
| Nov. 3, 2025 | EMR | A | 5,107 | · | · | 98,392 Direct | +5.47% | Acquired | (price as of 2026-10-02) |
| June 2, 2025 | CAL | A | 12,131 | $13.19 | $160,008 | 12,131 Direct | · | Acquired | -7.4% (price as of 2026-10-02) |
| Nov. 6, 2024 | EMR | F | 1,004 | $125.44 | $125,942 | 82,224 Direct | -1.21% | Disposed | 28.8% (price as of 2026-10-02) |
| Nov. 4, 2024 | EMR | A | 5,734 | · | · | 83,228 Direct | +7.40% | Acquired | (price as of 2026-10-02) |
| Nov. 4, 2024 | EMR | F | 6,530 | $109.11 | $712,488 | 77,494 Direct | -7.77% | Disposed | 48.1% (price as of 2026-10-02) |
| Nov. 4, 2024 | EMR | A | 14,790 | · | · | 84,024 Direct | +21.36% | Acquired | (price as of 2026-10-02) |
| June 3, 2024 | CAL | A | 4,564 | $35.06 | $160,014 | 4,564 Direct | · | Acquired | -65.1% (price as of 2026-10-02) |
| Nov. 6, 2023 | EMR | A | 6,820 | · | · | 69,234 Direct | +10.93% | Acquired | (price as of 2026-10-02) |
| Nov. 6, 2023 | EMR | A | 8,406 | · | · | 62,414 Direct | +15.56% | Acquired | (price as of 2026-10-02) |
| Sept. 6, 2023 | EMR | M | 4,617 | · | · | 0 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 6, 2023 | EMR | F | 3,059 | $98.23 | $300,486 | 54,008 Direct | -5.36% | Disposed | 64.5% (price as of 2026-10-02) |
| Sept. 6, 2023 | EMR | M | 4,617 | $65.07 | $300,428 | 57,067 Direct | +8.80% | Acquired | 148.4% (price as of 2026-10-02) |
| July 20, 2023 | EMR | M | 1,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| July 20, 2023 | EMR | F | 298 | $92.28 | $27,499 | 52,450 Direct | -0.56% | Disposed | 75.1% (price as of 2026-10-02) |
| July 20, 2023 | EMR | M | 1,000 | · | · | 52,748 Direct | +1.93% | Acquired | (price as of 2026-10-02) |
| June 27, 2023 | EMR | S | 48,718 | $89.65 | $4,367,569 | 51,748 Direct | -48.49% | Disposed | 80.3% (price as of 2026-10-02) |
| June 5, 2023 | CAL | A | 7,756 | $19.34 | $150,001 | 7,756 Direct | · | Acquired | -36.8% (price as of 2026-10-02) |
| Oct. 31, 2022 | EMR | A | 8,162 | · | · | 100,466 Direct | +8.84% | Acquired | (price as of 2026-10-02) |
| May 26, 2022 | CAL | A | 5,235 | $27.70 | $145,010 | 5,235 Direct | · | Acquired | -55.9% (price as of 2026-10-02) |
| Nov. 1, 2021 | EMR | A | 10,000 | · | · | 92,304 Direct | +12.15% | Acquired | (price as of 2026-10-02) |
| Nov. 1, 2021 | EMR | A | 7,221 | · | · | 82,304 Direct | +9.62% | Acquired | (price as of 2026-10-02) |
| June 2, 2021 | CAL | A | 4,910 | $27.50 | $135,025 | 4,910 Direct | · | Acquired | -55.6% (price as of 2026-10-02) |
| June 8, 2020 | CAL | A | 12,748 | · | · | 12,748 Direct | · | Acquired | (price as of 2026-10-02) |
| June 5, 2019 | CAL | A | 6,457 | · | · | 6,457 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 8, 2026 | CAL | Restricted Stock Units | Common Stock | · | · | 12,196 | Acquired |
| June 2, 2025 | CAL | Restricted Stock Units | Common Stock | · | · | 12,131 | Acquired |
| June 3, 2024 | CAL | Restricted Stock Units | Common Stock | · | · | 4,564 | Acquired |
| Sept. 6, 2023 | EMR | Employee Stock option (Right to Buy) | Common Stock | $65.07 | Oct. 1, 2023 | 4,617 | Acquired |
| July 20, 2023 | EMR | Restricted Stock Units | Common Stock | · | · | 1,000 | Disposed |
| June 5, 2023 | CAL | Restricted Stock Units | Common Stock | · | · | 7,756 | Acquired |
| May 26, 2022 | CAL | Restricted Stock Units | Common Stock | · | · | 5,235 | Acquired |
| June 2, 2021 | CAL | Restricted Stock Units | Common Stock | · | · | 4,910 | Acquired |
| June 8, 2020 | CAL | Restricted Stock Units | Common Stock | · | · | 12,748 | Acquired |
| June 5, 2019 | CAL | Restricted Stock Units | Common Stock | · | · | 6,457 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| March 12, 2021 | EMR | Common Stock | 75,083 | Direct |
| March 12, 2021 | EMR | Common Stock | 4,097 | Indirect |
| March 12, 2021 | EMR | Common Stock | 1,869 | Indirect |
| March 12, 2021 | EMR | Employee Stock Option (right to buy) | 4,617 | Direct |
| March 12, 2021 | EMR | Restricted Stock Units | 1,000 | Direct |
| March 26, 2019 | CAL | No Securities Beneficially Owned | 0 | Direct |